A Study to Assess the Safety of Myozyme® and of Aldurazyme® in Male and Female Participants of Any Age Group With Pompe Disease or With Mucopolysaccharidosis Type I (MPS I) in a Home-care Setting
Clinical trial NCT05073783 · COMPLETED
Trial details
- NCT number
- NCT05073783
- Sponsor
- Sanofi
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-10-14
- Primary completion
- 2024-01-31
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.